{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20135433,Language='IT')/Transcripts"}},"ID":20135433,"Language":"IT","BusinessShortNumber":"13.5433","BusinessType":14,"BusinessTypeName":"Ora delle domande. Domanda","BusinessTypeAbbreviation":"Dom.","Title":"Mondializzazione degli studi clinici. Che fa Swissmedic quando gli studi clinici effettuati nei paesi terzi violano le norme etiche?","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>Numerosi studi clinici avvengono in paesi emergenti dove una parte della popolazione \u00e8 disposta a parteciparvi per accedere alle cure e guadagnare qualcosa. Ci\u00f2 pone dei problemi etici, ad esempio a causa di trattamenti standard non omologati o di procedure di consenso discutibili.</p><p>1. Che intende fare il Consiglio federale affinch\u00e9 si tenga conto anche degli aspetti etici nell'omologare dei medicamenti?</p><p>2. In particolare ritiene che Swissmedic debba valutare anche questi aspetti?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":null,"FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":null,"SubmittedBy":"Carobbio Guscetti Marina","BusinessStatus":229,"BusinessStatusText":"Liquidato","BusinessStatusDate":"\/Date(1379894400000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"Dipartimento dell'interno","ResponsibleDepartmentAbbreviation":"DFI","IsLeadingDepartment":true,"Tags":"2841","Category":null,"Modified":"\/Date(1690529491427)\/","SubmissionDate":"\/Date(1379462400000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Consiglio nazionale","SubmissionCouncilAbbreviation":"CN","SubmissionSession":4910,"SubmissionLegislativePeriod":49,"FirstCouncil1":null,"FirstCouncil1Name":null,"FirstCouncil1Abbreviation":null,"FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Salute"}}